Join our first Helpline Live: Biosimilars and You – a Q&A

We know that a lot of people taking Humira (adalimumab) are being contacted by the rheumatology departments about switching to biosimilars. We are taking quite a few calls on our Helpline on the issue and thought it would be useful to run a Facebook Live Helpline session.

The session will run from 1300 to 1330 on Friday 29 March.

You can find the NASS Facebook page here:

Head of Information & Support Services, Sally Dickinson, will talk about the adalimumab biosimilars and your options and rights. If you have questions you can email them to Sally in advance by Thursday 28 March or you can ask questions during the session.

Do bear in mind that Sally is not a heath professional and can only give general advice.

We hope you can join us.